[go: up one dir, main page]

PE20161345A1 - Composicion antifungica topica para el tratamiento de onicomicosis - Google Patents

Composicion antifungica topica para el tratamiento de onicomicosis

Info

Publication number
PE20161345A1
PE20161345A1 PE2016001254A PE2016001254A PE20161345A1 PE 20161345 A1 PE20161345 A1 PE 20161345A1 PE 2016001254 A PE2016001254 A PE 2016001254A PE 2016001254 A PE2016001254 A PE 2016001254A PE 20161345 A1 PE20161345 A1 PE 20161345A1
Authority
PE
Peru
Prior art keywords
treatment
onichomycosis
antifungal composition
composition
topical antifungal
Prior art date
Application number
PE2016001254A
Other languages
English (en)
Inventor
Daniela Ceriani
Simone Sarno
Federico Mailland
Giuliana Iob
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50150638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20161345(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of PE20161345A1 publication Critical patent/PE20161345A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Se refiere a una composicion que consiste en: a) ciclopirox y/o al menos una sal farmaceuticamente aceptable del mismo en una cantidad de al menos 7% en peso y/o una sal de la misma, tal como ciclopirox olamina, b) hidroxipropil quitosano, c) agua y d) al menos un alcanol C1-C4; cuya composicion no contiene plastificantes y/o intensificadores de la penetracion. Donde dicha composicion puede estar en forma de barniz de unas, siendo util en el tratamiento de onicomicosis
PE2016001254A 2014-02-21 2015-02-18 Composicion antifungica topica para el tratamiento de onicomicosis PE20161345A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14156113.4A EP2910245A1 (en) 2014-02-21 2014-02-21 Topical antifungal composition for treating onychomycosis

Publications (1)

Publication Number Publication Date
PE20161345A1 true PE20161345A1 (es) 2016-12-17

Family

ID=50150638

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2016001254A PE20161345A1 (es) 2014-02-21 2015-02-18 Composicion antifungica topica para el tratamiento de onicomicosis

Country Status (18)

Country Link
US (1) US20170056386A1 (es)
EP (2) EP2910245A1 (es)
JP (1) JP2017506647A (es)
KR (1) KR20160121538A (es)
CN (1) CN106102717A (es)
AR (1) AR099405A1 (es)
AU (1) AU2015220883A1 (es)
CA (1) CA2938922A1 (es)
CL (1) CL2016002083A1 (es)
DO (1) DOP2016000213A (es)
EA (1) EA201691687A1 (es)
IL (1) IL246800A0 (es)
MD (1) MD20160097A2 (es)
MX (1) MX2016010787A (es)
PE (1) PE20161345A1 (es)
PH (1) PH12016501661A1 (es)
UY (1) UY36007A (es)
WO (1) WO2015124586A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106580927A (zh) * 2017-02-17 2017-04-26 中国药科大学 一种环吡酮胺喷膜剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
DE69907341T2 (de) 1998-02-09 2004-01-22 Macrochem Corp., Lexington Antimykotischer nagellack
JP5170486B2 (ja) 1998-09-10 2013-03-27 バイオイコール ア−ゲー 局所適用性産物
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
EP1958638A1 (en) * 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans to increase nail growth rate

Also Published As

Publication number Publication date
IL246800A0 (en) 2016-08-31
CA2938922A1 (en) 2015-08-27
MD20160097A2 (ro) 2016-12-31
UY36007A (es) 2015-04-30
EA201691687A1 (ru) 2016-12-30
DOP2016000213A (es) 2016-11-30
AU2015220883A1 (en) 2016-08-25
CN106102717A (zh) 2016-11-09
EP2910245A1 (en) 2015-08-26
EP3107528A1 (en) 2016-12-28
WO2015124586A1 (en) 2015-08-27
JP2017506647A (ja) 2017-03-09
KR20160121538A (ko) 2016-10-19
PH12016501661A1 (en) 2016-10-03
CL2016002083A1 (es) 2017-06-09
US20170056386A1 (en) 2017-03-02
MX2016010787A (es) 2017-04-06
AR099405A1 (es) 2016-07-20

Similar Documents

Publication Publication Date Title
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CL2017000287A1 (es) 2-(morfolin-4-il)-1,7-naftiridinas.
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
CO2017005995A2 (es) Composiciones para el cuidado bucal y métodos de uso
BR112016026291A2 (pt) Derivados do ácido borônico e usos terapêuticos dos mesmos
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
CR20160099A (es) Formulación de inhibidores de la syk
PH12018500071B1 (en) Plinabulin compositions
AR102203A1 (es) Composiciones para el cuidado oral que comprenden zinc, arginina y serina
CL2016003329A1 (es) Derivados de indano e indolina y el uso de los mismos como activadores de la guanilato ciclasa soluble
CO2017006898A2 (es) Formulación de relación fija de insulina glargina/lixisenatida
MX2018004033A (es) Composicion acuosa que contiene dantroleno.
AR091039A1 (es) Composiciones farmaceuticas topicas que comprenden terbinafina, uso y metodo de tratamiento
ECSP17005294A (es) Composición adhesiva
EA201890212A1 (ru) Новое применение сульфата декстрана
MX2018002015A (es) Composicion de absorcion percutanea.
PE20151300A1 (es) Composicion antifungica topica para el tratamiento de onicomicosis
PE20161345A1 (es) Composicion antifungica topica para el tratamiento de onicomicosis
UY36034A (es) Derivados de 3,5-diamino-6-cloro-pirazina-2-carboxamida y sales farmaceuticamente aceptables de estos
PE20150022A1 (es) Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis
CL2018001236A1 (es) Composición farmacéutica que contiene, como ingrediente activo, derivado de 7-azaindolin-2-ona o sal farmacéuticamente aceptable del mismo.
AR095145A1 (es) Composición antifúngica tópica para el tratamiento de onicomicosis
AR099224A1 (es) Derivados de piperidina con actividad multimodal contra el dolor
AR107458A2 (es) Formulación acuosa estable de color para el tratamiento de plantas que crecen en forma orgánica
CL2011001916A1 (es) Uso de ezatiostat o una sal de el para el tratamiento del sindrome mielodisplasico; composicion farmaceutica que comprende a dicho compuesto ademas de lenalidomida; combinacion farmaceutica; kit farmaceutico.

Legal Events

Date Code Title Description
FD Application declared void or lapsed